HIGHLIGHTS
- who: Amanda Bortolini Silveira from the (UNIVERSITY) have published the Article: Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer, in the Journal: (JOURNAL)
- what: The authors have investigated the clinical value of concomitant analysis of CTCs and ctDNA. In that context, the study demonstrates that CTCs and ctDNA, which stem from very different biological processes, should be considered as yielding complementary and nonoverlapping clinical information. To increase the sensitivity of the approach (see below), whenever a variant was identified in FFPE tumor tissue, the same variant was systematically . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.